Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC

This study has been terminated.
(Poor accrual)
Novartis Pharmaceuticals
Information provided by (Responsible Party):
University of Chicago Identifier:
First received: February 3, 2010
Last updated: January 16, 2014
Last verified: January 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2012
  Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)